Skip to main content

Springer Timothy A's Form 4 filing

Tectonic Therapeutic, Inc.TECX · filed Apr 11, 2025

Accession no.
0001415889-25-010588
Filed
Apr 11, 2025
Trade date
Apr 9-11, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 8 non-derivative transactions. Open-market purchases total $2.30M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Springer Timothy ACIK 0001055624Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 9, 2025Common StockPPurchaseAcquired+2,861$14.62F1+$41,827.824,316,419Direct
Apr 9, 2025Common StockPPurchaseAcquired+857$15.23F2+$13,052.114,317,276Direct
Apr 10, 2025Common StockPPurchaseAcquired+8,092$16.73F3+$135,379.164,325,368Direct
Apr 11, 2025Common StockPPurchaseAcquired+9,478$16.31F4+$154,586.184,334,846Direct
Apr 9, 2025Common StockPPurchaseAcquired+16,215$14.62F1+$237,063.31,398,938Indirect
Apr 9, 2025Common StockPPurchaseAcquired+4,856$15.23F2+$73,956.881,403,794Indirect
Apr 10, 2025Common StockPPurchaseAcquired+45,858$16.73F3+$767,204.341,449,652Indirect
Apr 11, 2025Common StockPPurchaseAcquired+53,706$16.31F4+$875,944.861,503,358Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $13.9869 to $14.9578 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

F2

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.1994 to $15.2452 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

F3

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $16.29 to $17.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

F4

The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $15.96 to $16.68 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Referenced by the price of 2 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)